Updated on 3 October 2026
CardioNéo — Seeking a Strategic Equity Investor
Co-founder & Managing Director at Iavoxel
Oujda, Morocco
About
iAvoxel is developing CardioNéo, a medical device project intended to support clinical assessment and referral in neonatal cardiovascular care.
We are seeking a strategic equity investor to support prototype refinement, technical and safety testing, preparation for a clinical investigation subject to the required ethical and regulatory approvals, and the applicable regulatory conformity steps.
The project is under development; clinical performance has yet to be established. CardioNéo is intended to support clinical decision-making. It is not intended to provide an autonomous diagnosis. Clinical decisions remain the responsibility of qualified healthcare professionals.
The investment amount, financing structure and partnership terms would be defined following a detailed project and budget review, with verifiable milestones and mutual commitments.
Detailed technical information will be shared selectively under confidentiality arrangements.
Organisation
Similar opportunities
Investment
Neuromodulation — Seeking Investment and Co-development Partners
Abdelkarim Elmahi
Co-founder & Managing Director at Iavoxel
Oujda, Morocco
Partnership
Research, Medtech and Digital Health Partnerships with iAvoxel
- Research
- Business
- Joint development
- Knowledge transfer
- Technology transfer
- Testing of technology
Abdelkarim Elmahi
Co-founder & Managing Director at Iavoxel
Oujda, Morocco
Service
Scientific Research, Medical Engineering and Digital Health Services
- Consulting
- Testing & Analysis
- Innovation management
- Research & Development
Abdelkarim Elmahi
Co-founder & Managing Director at Iavoxel
Oujda, Morocco